Abbott Laboratories

NYSE:ABT   3:59:57 PM EDT
125.10
+1.78 (+1.45%)
4:00:00 PM EDT: $125.04 -0.06 (-0.04%)
Products

Abbott Laboratories Receives FDA Approval For Minimally Invasive Portico With FlexNav TAVR System

Published: 09/20/2021 13:32 GMT
Abbott Laboratories (ABT) - Abbott Receives FDA Approval for Minimally Invasive Portico™ With Flexnav™ Tavr System to Treat Patients With Aortic Valve Disease.